165 related articles for article (PubMed ID: 12323401)
21. Genotypic and phenotypic characterization of the thymidine kinase of ACV-resistant HSV-1 derived from an acyclovir-sensitive herpes simplex virus type 1 strain.
Saijo M; Suzutani T; De Clercq E; Niikura M; Maeda A; Morikawa S; Kurane I
Antiviral Res; 2002 Dec; 56(3):253-62. PubMed ID: 12406508
[TBL] [Abstract][Full Text] [Related]
22. The cotton rat model for adenovirus ocular infection: antiviral activity of cidofovir.
Kaneko H; Mori S; Suzuki O; Iida T; Shigeta S; Abe M; Ohno S; Aoki K; Suzutani T
Antiviral Res; 2004 Jan; 61(1):63-6. PubMed ID: 14670595
[TBL] [Abstract][Full Text] [Related]
23. Inhibitory effect of (S)-HPMPC, (S)-HPMPA, and 2'-nor-cyclic GMP on clinical ocular adenoviral isolates is serotype-dependent in vitro.
Gordon YJ; Romanowski E; Araullo-Cruz T; Seaberg L; Erzurum S; Tolman R; De Clercq E
Antiviral Res; 1991 Jul; 16(1):11-6. PubMed ID: 1776874
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory activity of alkoxyalkyl and alkyl esters of cidofovir and cyclic cidofovir against orthopoxvirus replication in vitro.
Keith KA; Wan WB; Ciesla SL; Beadle JR; Hostetler KY; Kern ER
Antimicrob Agents Chemother; 2004 May; 48(5):1869-71. PubMed ID: 15105146
[TBL] [Abstract][Full Text] [Related]
25. Alkoxyalkyl esters of cidofovir and cyclic cidofovir exhibit multiple-log enhancement of antiviral activity against cytomegalovirus and herpesvirus replication in vitro.
Beadle JR; Hartline C; Aldern KA; Rodriguez N; Harden E; Kern ER; Hostetler KY
Antimicrob Agents Chemother; 2002 Aug; 46(8):2381-6. PubMed ID: 12121908
[TBL] [Abstract][Full Text] [Related]
26. Mechanism of inhibition of vaccinia virus DNA polymerase by cidofovir diphosphate.
Magee WC; Hostetler KY; Evans DH
Antimicrob Agents Chemother; 2005 Aug; 49(8):3153-62. PubMed ID: 16048917
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of multiple- or single-dose cidofovir against vaccinia and cowpox virus infections in mice.
Quenelle DC; Collins DJ; Kern ER
Antimicrob Agents Chemother; 2003 Oct; 47(10):3275-80. PubMed ID: 14506041
[TBL] [Abstract][Full Text] [Related]
28. Characterization of wild-type and cidofovir-resistant strains of camelpox, cowpox, monkeypox, and vaccinia viruses.
Smee DF; Sidwell RW; Kefauver D; Bray M; Huggins JW
Antimicrob Agents Chemother; 2002 May; 46(5):1329-35. PubMed ID: 11959564
[TBL] [Abstract][Full Text] [Related]
29. Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitro.
Williams-Aziz SL; Hartline CB; Harden EA; Daily SL; Prichard MN; Kushner NL; Beadle JR; Wan WB; Hostetler KY; Kern ER
Antimicrob Agents Chemother; 2005 Sep; 49(9):3724-33. PubMed ID: 16127046
[TBL] [Abstract][Full Text] [Related]
30. High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes.
Smith IL; Cherrington JM; Jiles RE; Fuller MD; Freeman WR; Spector SA
J Infect Dis; 1997 Jul; 176(1):69-77. PubMed ID: 9207351
[TBL] [Abstract][Full Text] [Related]
31. Isolation and analysis of an aciclovir-resistant murine cytomegalovirus mutant.
Minematsu T; Mori S; Eizuru Y; Minamishima Y
Antiviral Res; 2001 Jan; 49(1):25-33. PubMed ID: 11166858
[TBL] [Abstract][Full Text] [Related]
32. Topical HPMPC inhibits adenovirus type 5 in the New Zealand rabbit ocular replication model.
Gordon YJ; Romanowski EG; Araullo-Cruz T
Invest Ophthalmol Vis Sci; 1994 Nov; 35(12):4135-43. PubMed ID: 7960596
[TBL] [Abstract][Full Text] [Related]
33. The in vitro and in vivo evaluation of ddC as a topical antiviral for ocular adenovirus infections.
Romanowski EG; Yates KA; Gordon YJ
Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5295-9. PubMed ID: 19516011
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections.
De Clercq E
Verh K Acad Geneeskd Belg; 1996; 58(1):19-47; discussion 47-9. PubMed ID: 8701600
[TBL] [Abstract][Full Text] [Related]
35. Intravenous Cidofovir therapy for disseminated adenovirus in a pediatric liver transplant recipient.
Carter BA; Karpen SJ; Quiros-Tejeira RE; Chang IF; Clark BS; Demmler GJ; Heslop HE; Scott JD; Seu P; Goss JA
Transplantation; 2002 Oct; 74(7):1050-2. PubMed ID: 12394854
[TBL] [Abstract][Full Text] [Related]
36. Genetic analysis of a clinical isolate of human cytomegalovirus exhibiting resistance against both ganciclovir and cidofovir.
Harada K; Eizuru Y; Isashiki Y; Ihara S; Minamishima Y
Arch Virol; 1997; 142(2):215-25. PubMed ID: 9125039
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, metabolic stability and antiviral evaluation of various alkoxyalkyl esters of cidofovir and 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]adenine.
Ruiz J; Beadle JR; Buller RM; Schreiwer J; Prichard MN; Keith KA; Lewis KC; Hostetler KY
Bioorg Med Chem; 2011 May; 19(9):2950-8. PubMed ID: 21493074
[TBL] [Abstract][Full Text] [Related]
38. Antiviral activity of cidofovir against telomerase-specific replication-selective oncolytic adenovirus, OBP-301 (Telomelysin).
Ouchi M; Kawamura H; Urata Y; Fujiwara T
Invest New Drugs; 2009 Jun; 27(3):241-5. PubMed ID: 18754077
[TBL] [Abstract][Full Text] [Related]
39. Mutations conferring resistance to viral DNA polymerase inhibitors in camelpox virus give different drug-susceptibility profiles in vaccinia virus.
Duraffour S; Andrei G; Topalis D; Krečmerová M; Crance JM; Garin D; Snoeck R
J Virol; 2012 Jul; 86(13):7310-25. PubMed ID: 22532673
[TBL] [Abstract][Full Text] [Related]
40. Genetic diversity of the human adenovirus species C DNA polymerase.
Feghoul L; Mercier-Delarue S; Salmona M; Ntsiba N; Dalle JH; Baruchel A; Klonjkowski B; Richardson J; Simon F; LeGoff J
Antiviral Res; 2018 Aug; 156():1-9. PubMed ID: 29842914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]